AGP Executive Report
Last update: 9 hours agoEarthquake & Tsunami Response: A powerful 7.8-magnitude quake struck off Sarangani, Mindanao, killing at least 15 and injuring 100+ as buildings collapsed and tsunami warnings were issued across the Philippines, Indonesia, Palau, Taiwan and Papua New Guinea, with authorities urging coastal residents to move to higher ground. Taiwan Health Diplomacy: Chinese Taipei pledged US$1.5 million to APEC’s first dedicated healthcare sub-fund, aiming to strengthen primary care, expand telemedicine and support policy work on aging and chronic disease. Healthcare Research & Drugs: Antengene shared first preclinical data on ATG-207 at EULAR, showing regulatory T-cell induction and immune tolerance in animal models; Dayspring Pharma reported positive Phase II topline results for CG2001 (minoxidil/finasteride) in male androgenetic alopecia. Metabolic Health Breakthroughs: Zealand Pharma highlighted detailed Phase III analyses for survodutide in obesity, reporting targeted visceral and liver fat reductions with limited lean mass loss. Public Health & Community: Taipei’s shelter intake of puppies dropped at least 88% after high-intensity sterilization, with reduced free-roaming dog numbers and fewer human-dog conflicts. Ophthalmology Deal: Everest Medicines acquired Greater China rights for VIZZ® (aceclidine eye drops) from Corxel, with approval expected in China in Q1 2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
